Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Total Receivables: €1.62 Mil (As of Dec. 2025)


MIL:ERFO Laboratorio Farmaceutico Erfo SpA MIL:ERFO
67 GF Score
Price €1.16
GF Value €2.11
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Laboratorio Farmaceutico Erfo SpA Total Receivables?

Laboratorio Farmaceutico Erfo SpA MIL:ERFO -0.43% 67 Total Receivables is €1.62 Mil as of Dec. 2025. GuruFocus rates MIL:ERFO with a GF Score™ of 67/100 and a GF Value™ of €2.11 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Laboratorio Farmaceutico Erfo SpA's Total Receivables for the quarter that ended in Dec. 2025 was €1.62 Mil.

Laboratorio Farmaceutico Erfo SpA Total Receivables Related Terms

Laboratorio Farmaceutico Erfo SpA Total Receivables Historical Data

* Premium members only.

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Farmaceutico Erfo SpA Total Receivables Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial 0.47 0.00 0.94 0.90 1.62

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 1.00 0.90 1.55 1.62
MIL:ERFO
67GF Score
Laboratorio Farmaceutico Erfo SpA MIL:ERFO
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorio Farmaceutico Erfo SpA Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €1.62 Mil mean?
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a Total Receivables of €1.62 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors.
Is Laboratorio Farmaceutico Erfo SpA's Total Receivables too high?
Laboratorio Farmaceutico Erfo SpA's current Total Receivables is €1.62 Mil. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's Total Receivables compare to KHC and GIS?
Laboratorio Farmaceutico Erfo SpA's Total Receivables of €1.62 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Consumer Packaged Goods company?
A good Total Receivables depends on the Consumer Packaged Goods industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. Laboratorio Farmaceutico Erfo SpA's current Total Receivables is €1.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.11, compared to a current price of €1.16 — trading 45% below its estimated fair value. The current Total Receivables is €1.62 Mil. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current Total Receivables is €1.62 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued. The current stock price of €1.16 is trading 45% below its estimated GF Value™ of €2.11. GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.

Key valuation signals for MIL:ERFO:

  • Total Receivables: €1.62 Mil
  • GF Value™: €2.11 vs. price of €1.16 (45% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorio Farmaceutico Erfo SpA Business Description

Address Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
67GF Score

Get the complete analysis for MIL:ERFO

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.16
Price
€2.11
GF Value